Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors

11 Jan 2001

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 11313942
DOI: 10.1038/sj.onc.1204056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factorsPMID 11313942Read ↗

A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusionSemantic proximity Read ↗

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinomaSemantic proximity Read ↗

Identification of a novel PARP14‐TFE3 gene fusion from 10‐year‐old FFPE tissue by RNA‐seqSemantic proximity Read ↗

Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell CarcinomasSemantic proximity Read ↗

Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomasSemantic proximity Read ↗

Fusion of the transcription factor <i>TFE3</i> gene to a novel gene, <i>PRCC</i> , in t(X;1)(p11;q21)-positive papillary renal cell carcinomasSemantic proximity Read ↗

Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.Semantic proximity Read ↗

Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancersSemantic proximity Read ↗

Gene fusion analysis in renal cell carcinoma by FusionPlex RNA‐sequencing and correlations of molecular findings with clinicopathological featuresSemantic proximity Read ↗

The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesisSemantic proximity Read ↗

Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PARP1 mRNA and downregulating PTENSemantic proximity Read ↗

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.